GW’s cannabis-derived drug succeeds in third epilepsy study
Britain's GW Pharmaceuticals Plc said its experimental cannabis-derived drug for a rare form of childhood epilepsy succeeded in a third late-stage U.S. study. Both tested doses of the drug, epidiolex,…